Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Champions Oncology, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −4 vs. Q1 2025
- Shares held
- 5.77M
- −144.6K (−2.4%) vs. Q1 2025
- Total value
- $42.5M
- −$8.82M (−17.2%) vs. Q1 2025
- New holders
- 4
- 8 more added
- Sold out
- 8
- 7 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CSBR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $36.3M |
| Q1 2026 | 25 | $33.0M |
| Q4 2025 | 27 | $39.7M |
| Q3 2025 | 27 | $36.7M |
| Q2 2025 | 30 | $42.5M |
| Q1 2025 | 34 | $51.4M |
| Q4 2024 | 25 | $49.0M |
| Q3 2024 | 22 | $28.2M |
| Q2 2024 | 23 | $29.9M |
| Q1 2024 | 25 | $27.6M |
| Q4 2023 | 23 | $31.5M |
| Q3 2023 | 29 | $35.6M |
| Q2 2023 | 28 | $37.0M |
| Q1 2023 | 30 | $23.6M |
| Q4 2022 | 29 | $27.1M |
| Q3 2022 | 32 | $46.8M |
| Q2 2022 | 32 | $49.8M |
| Q1 2022 | 30 | $50.4M |
| Q4 2021 | 31 | $51.7M |
| Q3 2021 | 35 | $64.1M |
| Q2 2021 | 38 | $68.5M |
| Q1 2021 | 45 | $81.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Champions Oncology, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Battery Management Corp. | 2,421,673 | $17.8M | 3.14% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,713,720 | $12.6M | 0.95% | 00.0% | Unchanged |
| Tocqueville Asset Management L.P. | 399,882 | $2.95M | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 327,029 | $2.41M | 0.00% | +19,155+6.2% | Added |
| Renaissance Technologies LLC | 181,039 | $1.33M | 0.00% | +29,000+19.1% | Added |
| Morgan Stanley | 130,500 | $961.8K | 0.00% | +42,068+47.6% | Added |
| BlackRock, Inc. | 120,829 | $890.5K | 0.00% | +4,970+4.3% | Added |
| Geode Capital Management, LLC | 75,185 | $554.2K | 0.00% | +51+0.1% | Added |
| Northern Trust Corp | 53,762 | $396.2K | 0.00% | −200−0.4% | Reduced |
| Acadian Asset Management LLC | 36,182 | $264.0K | 0.00% | −3,329−8.4% | Reduced |
| HighTower Advisors, LLC | 35,158 | $259.1K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 33,930 | $250.1K | 0.00% | −92,600−73.2% | Reduced |
| Bank of New York Mellon Corp | 26,749 | $197.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 26,203 | $193.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 25,280 | $186.3K | 0.00% | +70.0% | Added |
| Hillsdale Investment Management Inc. | 25,100 | $185.0K | 0.01% | −1,000−3.8% | Reduced |
| Millennium Management LLC | 24,064 | $177.4K | 0.00% | −42,549−63.9% | Reduced |
| Dimensional Fund Advisors LP | 22,405 | $165.1K | 0.00% | +22,405 | New |
| O'Shaughnessy Asset Management, LLC | 18,558 | $136.8K | 0.00% | −362−1.9% | Reduced |
| Jane Street Group, LLC | 17,667 | $130.2K | 0.00% | −5,353−23.3% | Reduced |
| XTX Topco Ltd | 14,034 | $103.4K | 0.00% | +14,034 | New |
| Cambridge Investment Research Advisors, Inc. | 12,252 | $90.0K | 0.00% | 00.0% | Unchanged |
| Mesirow Financial Investment Management, Inc. | 12,000 | $88.4K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 10,415 | $77.0K | 0.01% | +10,415 | New |
| Royal Bank of Canada | 7,728 | $57.0K | 0.00% | +102+1.3% | Added |
| Lazard Asset Management LLC | 1,349 | $9.00K | 0.00% | +1,349 | New |
| SBI Securities Co., Ltd. | 26 | $192 | 0.00% | +10+62.5% | Added |
| JPMorgan Chase & Co | 11 | $81 | 0.00% | 00.0% | Unchanged |
| Garde Capital, Inc. | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 48 | $0 | 0.00% | 00.0% | Unchanged |
| EAM Investors, LLC | 0 | $0 | 0.00% | −79,987−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −23,129−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −22,902−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −10,700−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,915−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −529−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −501−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |